Total Funding
1
7
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
347940
Acclarent is a medical device company that develops new technologies to treat patients suffering from ENT disorders.
Acquired by 
Integra LifeSciences
About the Company
Acclarent, Inc. is a medical device company. The company is dedicated to the development of innovative devices providing new technologies to further meet the needs of ENT patients.
Acclarent's initial focus is on achieving the goals of sinus surgery with novel, endoscopic, catheter-based tools—Balloon Sinuplasty® devices. Through the Balloon
SinuplastyTM technology and the company's RelievaTM registered product portfolio, we offer ENT patients alternatives to conventional endoscopic surgical approaches. FDA clearances for these devices were completed in 2005, and the products were commercially launched in the US that same year.
